Papers
38
Total Citations
1,508
H-Index
20
About
Senthil Nathan is a leading urological surgeon and researcher whose work has fundamentally shaped the practice of robotic and minimally invasive surgery, with a particular focus on bladder and prostate cancer. His most celebrated contribution — a landmark 2022 randomised controlled trial comparing robot-assisted radical cystectomy with intracorporeal urinary diversion to open surgery — has already garnered over 320 citations, providing critical evidence that robotic techniques can meaningfully reduce patient morbidity. This work builds on his earlier research demonstrating that combining intracorporeal robot-assisted radical cystectomy with enhanced recovery pathways achieves superior outcomes through the aggregation of marginal gains. Nathan has also made significant contributions to robotic surgical education, authoring widely cited reviews on training frameworks and learning curves that have helped standardise credentialling as robotic adoption has rapidly expanded. His technical innovations include describing the intracorporeal pyramid neobladder reconstruction, and he has advanced techniques for optimising urinary continence recovery following robotic prostatectomy. His clinical leadership extends to pioneering trials such as TRoMbone and NeuroSAFE PROOF, exploring cytoreductive surgery in oligometastatic prostate cancer and nerve-sparing techniques respectively. Collectively, his research portfolio reflects a commitment to rigorously improving surgical outcomes, training standards, and patient quality of life across urological oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2Training in Robotic Surgery—an Overview205 citations · 2017
- 3
- 4
- 5Learning Curves for Robotic Surgery: a Review of the Recent Literature71 citations · 2017
- 6Robot‐assisted intracorporeal pyramid neobladder70 citations · 2015
- 7
- 8
- 9
- 10